Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Antimicrobial Susceptibility Testing Market Growth Analysis: How Will Revenue Expand During The Forecast Period?
Fueled by escalating occurrences of infectious diseases, heightened consciousness surrounding antimicrobial resistance, the expansion of clinical microbiology facilities, a surge in hospital diagnostic testing, and the establishment of uniform AST methodologies, the market for antimicrobial susceptibility testing has experienced robust expansion. Projections indicate a continued upward trajectory, with the market anticipated to expand from $4.65 billion in 2025 to $4.93 billion in 2026, reflecting a compound annual growth rate of 6.0%.
The market for antimicrobial susceptibility testing is poised for significant expansion in the upcoming years, projected to reach $6.01 billion by 2030, reflecting a compound annual growth rate of 5.1%. This anticipated growth is propelled by several key factors, including heightened investments in swift diagnostic technologies, a greater uptake of AI-enhanced laboratory analysis, the broadening of antimicrobial resistance surveillance initiatives, a surge in demand for point-of-care AST solutions, and an intensified emphasis on personalized antimicrobial therapy. During this forecast period, prominent trends will involve a wider adoption of automated AST systems, escalating demand for rapid diagnostic testing, increased integration of both molecular and phenotypic methodologies, the expansion of laboratory automation solutions, and a more concentrated effort on monitoring antimicrobial resistance.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4026&type=smp
Antimicrobial Susceptibility Testing Market Growth Momentum: Which Factors Are Influencing Demand?
The escalating prevalence of infectious ailments worldwide has been a significant factor fueling the expansion of the antimicrobial susceptibility testing market. Such diseases stem from pathogens including bacteria, viruses, fungi, and parasites, with bacterial infections encompassing conditions like tuberculosis and bacterial pneumonia, while viral diseases include smallpox and AIDS. Demonstrating this trend, the Centers for Disease Control and Prevention reported in March 2024 that in 2023, out of 9,573 tuberculosis cases where the birthplace was identified, a notable 7,259 (76%) were among individuals not born in the U.S., marking an 18% surge from the 6,177 cases documented in 2022. Consequently, this increase in infectious disease occurrences directly propels the growth of the antimicrobial susceptibility testing market.
Antimicrobial Susceptibility Testing Market Categorization By Product Type And Application
The antimicrobial susceptibility testing market covered in this report is segmented –
1) By Testing Type: Antibacterial Testing, Antifungal Testing, Antiparasitic Testing, Other Testing Types
2) By Product: Manual Antimicrobial Susceptibility Testing Products, Automated Laboratory Instruments, Consumables
3) By Application: Diagnostics, Drug Discovery and Development, Epidemiology, Other Applications
4) By End User: Hospitals And Diagnostic Centers, Pharmaceutical And Biotechnology Companies, Research And Academic Institutes, Clinical Research Organizations (CROs)
Subsegments:
1) By Antibacterial Testing: Disk Diffusion Method, Broth Dilution Method, E-Test Method, Automated Systems
2) By Antifungal Testing: Broth Dilution Method, Agar Disk Diffusion Method, E-Test Method, Colorimetric Methods
3) By Antiparasitic Testing: In vitro Susceptibility Testing, Microscopic Examination, Molecular Methods
4) By Other Testing Types: Mycobacterial Susceptibility Testing, Biofilm Susceptibility Testing, Combination Antimicrobial Testing
Antimicrobial Susceptibility Testing Market Trends Reshaping Industry Growth
In the rapidly evolving antimicrobial susceptibility testing landscape, key industry players are actively introducing novel solutions, exemplified by the First POC Testing System. This groundbreaking device is designed to identify bacterial presence or absence and simultaneously evaluate the efficacy of antimicrobial treatments, utilizing patient urine samples when a urinary tract infection (UTI) is suspected. Its introduction marks a considerable advancement in AST methodologies, facilitating a quicker commencement of precise antimicrobial treatment for individuals battling infections. To illustrate, Sysmex Corporation, a prominent Japanese manufacturer specializing in clinical diagnostic reagents and equipment, particularly in hematology and immunology, unveiled an advanced testing system in June 2023 engineered for the swift determination of antimicrobial susceptibility. This system, leveraging proprietary microfluidic technology, provides AST results within a remarkable 30-minute timeframe from the commencement of testing, a substantial improvement over traditional methods that typically require multiple days.
Antimicrobial Susceptibility Testing Market Company Landscape And Strategic Competition
Major companies operating in the antimicrobial susceptibility testing market are BioMérieux SA, Becton Dickinson and Company, Thermo Fisher Scientific Inc., Danaher Corporation, Bio-Rad Laboratories Inc., Accelerate Diagnostics Inc., Alifax Holding S.p.A., Synbiosis Ltd., Mast Group Ltd., ELITechGroup, Genefluidics Inc., QuantaMatrix Inc., Bruker Corporation, Eurofins Scientific SE, Liofilchem s.r.l., Hardy Diagnostics, Bioanalyse GmbH, Lab M Limited, Microbiologics Inc., Quidel Corporation, R-Biopharm AG, SSI Diagnostica A/S
Access The Complete Antimicrobial Susceptibility Testing Market Report:
Antimicrobial Susceptibility Testing Market Global Footprint: Which Region Holds Market Leadership?
North America was the largest region in the antimicrobial susceptibility testing market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the antimicrobial susceptibility testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model